Weaver Mutant Mouse in Progression of Neurodegeneration in Parkinson’s Disease

Parkinson's Disease

Volumn , Issue , 2004, Pages 537-556

  Ebadi, Manuchair ^a   Sharma, Sushil ^a   Ajjimaporn, Amornpan ^a   Maanum, Scott ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Caspase 3 activity; Coenzyme Q 10; Complex 1 nitration; GIRK channel; Glutathione; NF activation; Parkinson s disease; Salsolinol; Serine (140) phosphorylation; Striatal DA; TNF synthesis; Tyrosine hydroxylase; Tyrosine nitration; Wv wv mice; synindex

Indexed keywords

EID: 85060542293     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780203508596-53     Document Type: Chapter

References (47)

1. Wei, J., Dlouhy, S. R., Bayer, S., Piva, R., Verina, T., Wang, Y., Feng, Y., Dupree, B., Hodes, M. E., Ghetti, B., In-situ hybridization analysis of GIRK2 expression in the developing central nervous system in normal and weaver mice, J. Neuropathol. Exp. Neurol., 56: 762–771, 1997.
2. Schein, J. C., Hunter, D. D., Rofler-Tarlov, S., GIRK-2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver, Dev. Biol., 204: 432–450, 1998.
3. Zhong, J., Deng, J., Ghetti, B., Lee, W. H., Inhibition of insulin-like growth factor I activity contributes to the premature apoptosis of cerebellar granular neurons in weaver mutant mice: in vitro analysis, J. Neuroscience., Res. 70: 36–45, 2002.
4. Blum, M., Weickert, C., Carrasco, E., The weaver GIRK2 mutation leads to decreased levels of serum thyroid hormone: Characterization of the effect on midbrain DA-ergic neuron survival, Exp. Neurol., 160: 413–424, 1999.
5. Peng, J., Wu, Z., Wu, Y., Hsu, M., Stevenson, F. F., Boonplueang, R., Roffler-Tarlov, S. K., Andersen, J. K., Inhibition of caspases protects cerebellar granular cells of the weaver mouse from apoptosis and improves behavioral phenotype, J. Biol. Chem., 277: 44285–44291, 2002.
6. Surmeier, D. J., Mermelstein, P. G., Goldwitz, D., The weaver mutation of GIRK-2 results in a loss of inwardly rectifying K+ current in cerebellar granule cells, Proc. Natl. Acad. Sci., U.S.A. 93:11191–11195, 1996.
7. Xu, S. G., Prasad, C., Smith, D. E., Neurons exhibiting DA D2 receptor immunoreactivity in the substantia nigra of the mutant weaver mouse, Neuroscience, 89: 191–207, 1999.
8. Xu, S. G., Prasad C. Smith, D. E., Neurons exhibiting DA D2 receptor immunoreactivity in the substantia nigra of the mutant weaver mouse, Neuroscience, 89: 191–207, 1999.
9. Simon, J. R., Richter, J. A., and Ghetti, B., Age-dependent alterations in DA content, tyrosine hydroxylase activity, and DA uptake in the striatum of the wv/wv mouse, J. Neurochem., 62: 543–548, 1994.
10. Migheli, A., Piva, R., Wei, J., Attanasio, A., Casolino, S., Hodes, M. E., Dlouhy, S. R., Bayer, S. A. and Ghetti, B., Diverse cell death pathways result from a single missense mutation in weaver mouse, Am. J. Pathol., 151:1629–1638, 1997.
11. Bandmann, O., Davis, M. B., Marsden, C. D. and Wood, N. W., The human homologue of the weaver mouse gene in familial and sporadic Parkinson’s disease, Neuroscience, 72: 877–879, 1996.
12. Neusch, C., Weishaupt, J. H. and Bahr, M., Kir channels in the CNS: Emerging new roles and implications for neurological diseases, Cell Tissue Res., 311: 131–138, 2003.
13. Rakic, P. and Sidman, R. L. Sequence of developmental abnormalities leading to granule cell deficit in cerebellar cortex of wv/wv mice, J. Comp. Neurol., 152: 103–132, 1973.
14. Harkins, A. B. and Fox, A. P., Cell death in weaver mouse cerebellum, Cerebellum, 1(3): 201–206, 2002.
15. Schmidt, M. J., Sawyer, B. D., Perry, K. W., Fuller, R. W., Foreman, M. M. and Ghetti, B., DA deficiency in wv/wv mouse, J. Neurosci., 2: 376-380, 1982.
16. Gupta, M., Felten, D. L. and Ghetti, B., Selective loss of monoaminergic neurons in wv/wv mice: an immunocytochemical study, Brain Res., 402: 379–382, 1987.
17. Triarhou, L. C., Norton, J. and Ghetti, B., Mesencephalic DA cell deficit involves areas A8, A9, and A10 in wv/wv mice, Exp. Brain Res., 70: 256–265, 1988.
18. Ghetti, B. and Triarhou, L. C., Combined degeneration of cerebellar granular cells and the midbrain DA neurons in the wv/wv mouse, in Progress in Parkinson’s Disease Research-2 (Hefti, F., and Weiner, W. J., Eds.), pp. 375–388, Futura Publishing, Mount Kisco, NY.
19. Maharajan, P., Maharajan, V., Ravagnan, G. and Paino, G., The wv/wv mouse: A model to study the ontogeny of DA-ergic transmission systems and their role in drug addiction, Prog. Neurobiol., 64: 269–276, 2001.
20. Lane, J. D., Nadi, N. S., McBride, W. J., Aprison, M. H. and Kusano, K., Contents of serotonin, norepinephrine, and DA in the cerebellum of the staggerer, weaver, and nervous, neurologically mutant mice, J. Neurochem., 29: 349–350, 1977.
21. Roffler-Tarlov, S. and Grabiel, A. M., Weaver mutation has differential effects on the DA-containing innervation of the limbic and nonlimbic striatum, Nature, 307:62–66, 1984.
22. Simon, J. R. and Ghetti, B., Topographical distribution of DA uptake, choline uptake, cholin acetyl transferase and GABA uptake in the striata of wv/wv mice, Neurochem Res., 17: 431–436, 1992.
23. Roffler-Tarlov, S. and Graybiel, A. M., The postnatal development of the DA containing innervation of dorsal and ventral striatum: Effects of the weaver gene, J. Neurosci., 7: 2364–2372, 1987.
24. Ghetti, B. and Triarhou, L. C., NS aberrations induced by weaver gene are present at birth, Soc. Neurosci. Abstr., 18: 156, 1992b.
25. Roffler-Tarlov, S. and Graybiel, A. M., Genetic effects on DA uptake sites in the striatum, Soc. Neurosci. Abstr., 17: 1289, 1991.
26. Sharma, S. K. and Ebadi, M., Metallothionein attenuates 3-Morpholinosydnonimine (SIN-1)-Induced Oxidative Stress in DA-rgic Neurons, Antioxidants and Redox Signaling, 5: 251–264, 2003.
27. Sharma, S., Kheradpezhou, Shavali S., Refaey, H. EI., Eken, J., Hagen, C. and Ebadi, M., Neuroprotective Actions of Coenzyme Q10 in Parkinson’s disease, Methods in Enzymology, Vol. 382, 2003(in press).
28. Schapira, A. H., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P. and Marsden, C. D., Mitochondrial complex-1 deficiency in Parkinson’s disease, J. Neurochem., 54: 823–827, 1990.
29. Sangchot, P., Sharma, S., Chetsawang, B., Porter, J., Govitropong, P. and Ebadi, M., Deferoxamine attenuates iron-induced oxidative stress and prevents mitochondrial aggregation and α-syn translocation in SK-N-SH cells in culture, Developmental Neurosci., 24: 143–153, 2002.
30. Sharma, S., Carlson, E. and Ebadi, M., Neuroprotective action of Selegiline in inhibiting 1-methyl, 4-phenyl, pyridinium ion (MPP+)-induced apoptosis in SK-N-SH neurons, J. Neurocytol., 2003.
31. Adelgrecht, A., Agid, Y. and Raisman-Vozari, R., Effect of the weaver mutation on the expression of DA membrane transporter, tyrosine hydroxylase, and vesicular monoamine transporter in DA-ergic neurons of the substantia nigra and the ventral tegmental area, Molecular Brain Res., 43: 291–300, 1996.
32. Verney, C., Febvert-Muzerelle, A. and Gasper, P., Early postnatal changes of the DA-ergic mesencephalic neurons in the wv/wv mouse, Brain Res. Dev. Brain Res., 89: 115–119, 1995.
33. Bayer, S. A., Wills, K. V., Triarhou, L. C., Verina, T., Thomas, J. D. and Ghetti, B., Selective vulnerability of late-generated DA-ergic neurons of the substantia nigra in wv/wv mice, Proc. Natl. Acad. Sci., U.S.A., 92: 9137–9140, 1995.
34. Ozaki, M., Hashikawa, T., Ikeda, K., Miyakawa, Y., Ichikawa, T., Ishihara, Y., Kumanishi, T. and Yano, R., Degeneration of pontine mossy fibers during cerebellar development in wv/wv mice, Eur. J. Neurosci., 16:565–574, 2002.
35. Dewar, K. M., Paquet, M. and Sequeira, A., Apparent DA D1 and D2 receptors in the wv/wv mouse: Receptor binding and coupling to adenyl cyclase, J. Neural Transm., 106: 487–497, 1999.
36. Wullner, U., Weller, M., Schulz, J. B., Krajewski, S., Reed, J. C. and Klockgether, T., BCl-2, Bax, and BCl-X expression in neuronal apoptosis: A study of mutant weaver and lurcher mice, Acta Neuropathol. (Berl.), 96: 233–238, 1998.
37. Hao, R., Norgren, R. B., Jr., Lau, Y. S. and Pfeiffer, R. F., Cerebrospinal fluid of Parkinson’s disease patients inhibits the growth and function of dopaminergic neurons in culture, Neurology, 45: 138–142, 1995.
38. Shavail, S., Ren, J. and Ebadi, M., Insulin-like growth factor-1 protects dopaminergic SH-SY5Y cells from Salsolinol-Induced toxicity, Neurosci. Lett., 340: 79–82, 2003.
39. Triarhou, Biology and Pathology of Weaver mutant mouse, Adv. Exp. Med. Biol., 517: 15–42, 2002.
40. Ebadi, M., Govitropong, P., Sharma, S., Muralikrishnan, D., Shavali, S., Pellet, L., Schafer, R., Albano, C. and Ekan, J., Ubiquinone (Coenzyme Q10) and mitochondria in Oxidative Stress of Parkinson’s Disease, Biological Signals and Receptors, 10:224–253, 2002.
41. Beal, M. F., Coenzyme Q10 in Neurodegenerative Diseases, Ann. N. Y. Acad. Sci., 991: 120–131, 2003.
42. Ebadi, M., Muralikrishnan, D., Sharma, S., Shavali, S., Eken, J., Sangchot, P., Chetsawang, B. and Brekke, L., Metallothionein provides ubiquinone-mediated neuroprotection in Parkinson’s disease, Proceedings of the Western Pharmacol. Soc., 45: 36–38, 2002.
43. Douhou, A., Debier, T., Murer, M. G., Do, L., Dufour, N., Blanchard, V., Moussaoui, S., Bohme, G. A., Agid, Y. and Raisman-Vozari, R., Effect of chronic treatment with riluzole on the NS DA-ergic system in wv/wv mice, Exp. Neurol., 176: 247–253, 2002.
44. Mitsacos, A., Tomiyama, M., Stasi, K., Giompres, P., Kouvelas, E. D., Cortes, R., Palacois, J. M., Mengod, G. and Triarhou, L. C., [3H] CNQX and NMDA-sensitive [3H]glutamate binding sites and AMPA receptor subunit RNA transcripts in the striatum of normal and wv/wv mice and affects of ventral mesencephalic grafts, Cell Transplant, 8: 11–23, 1999.
45. Airaksinen, M. S., Thoenen, H. and Meyer, M., Vulnerability of midbrain DA-ergic neurons in calbindin-D28k-deficient mice: lack of evidence for a neuroprotective role of endogenous calbindin in MPTPtreated and weaver mice, Eur. J. Neurosci., 9: 120–127, 1997.
46. Giassen, B. I., Duda, J. E., Murray, I. V., Chen, Q., Souza, J. M., Hurtig, H. I., Ischiropoulos, H., Trojanowski, J. Q. and Lee, V. M., Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions, Science, 290: 985–989, 2000.
47. Ebadi, M. and Sharma, S. K., Peroxynitrite and Mitochondrial Dysfunction in the Pathogenesis of Parkinson’s disease, Antioxidants and Redox Signaling, 5: 319–335, 2003.